secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K/A
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001641172-25-002400
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals regains full Nasdaq compliance after $8.3M raise and debt conversion
--------------------------------------------------------------------------------

- Submitted pro-forma financials showing stockholder's equity of $2.8M vs $2.5M minimum required.
- Raised $8.332M from at-the-market offering; converted $1.785M debt into 924,200 shares.
- Compliant with Market Value of Publicly Held Securities standard (>$1M) as of March 7, 2025.
- Nasdaq Capital Market Equity Standard compliance achieved as of March 31, 2025 and continuing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225002400/0001641172-25-002400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225002400/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer